1068 related articles for article (PubMed ID: 16368548)
21. [Extracellular matrix -- from basic research to clinical significance. An overview with special consideration of matrix metalloproteinases].
Hamacher S; Matern S; Roeb E
Dtsch Med Wochenschr; 2004 Sep; 129(38):1976-80. PubMed ID: 15375740
[TBL] [Abstract][Full Text] [Related]
22. Crystal structures of MMPs in complex with physiological and pharmacological inhibitors.
Maskos K
Biochimie; 2005; 87(3-4):249-63. PubMed ID: 15781312
[TBL] [Abstract][Full Text] [Related]
23. Series "matrix metalloproteinases in lung health and disease": Biological role of matrix metalloproteinases: a critical balance.
Löffek S; Schilling O; Franzke CW
Eur Respir J; 2011 Jul; 38(1):191-208. PubMed ID: 21177845
[TBL] [Abstract][Full Text] [Related]
24. Roles of MMP/TIMP in regulating matrix swelling and cell migration during chick corneal development.
Huh MI; Lee YM; Seo SK; Kang BS; Chang Y; Lee YS; Fini ME; Kang SS; Jung JC
J Cell Biochem; 2007 Aug; 101(5):1222-37. PubMed ID: 17295208
[TBL] [Abstract][Full Text] [Related]
25. Matrix metalloproteinases in skeletal muscles: friends or foes?
Alameddine HS
Neurobiol Dis; 2012 Dec; 48(3):508-18. PubMed ID: 22885251
[TBL] [Abstract][Full Text] [Related]
26. Expression and regulation of metalloproteinases and their inhibitors in intervertebral disc aging and degeneration.
Vo NV; Hartman RA; Yurube T; Jacobs LJ; Sowa GA; Kang JD
Spine J; 2013 Mar; 13(3):331-41. PubMed ID: 23369495
[TBL] [Abstract][Full Text] [Related]
27. Matrix metalloproteinases and metastasis.
Kleiner DE; Stetler-Stevenson WG
Cancer Chemother Pharmacol; 1999; 43 Suppl():S42-51. PubMed ID: 10357558
[TBL] [Abstract][Full Text] [Related]
28. Interplay of angiotensin II and angiotensin(1-7) in the regulation of matrix metalloproteinases of human cardiocytes.
Pan CH; Wen CH; Lin CS
Exp Physiol; 2008 May; 93(5):599-612. PubMed ID: 18296491
[TBL] [Abstract][Full Text] [Related]
29. Differential gene expression profiling of metalloproteinases and their inhibitors: a comparison between bovine intervertebral disc nucleus pulposus cells and articular chondrocytes.
Cui Y; Yu J; Urban JP; Young DA
Spine (Phila Pa 1976); 2010 May; 35(11):1101-8. PubMed ID: 20473119
[TBL] [Abstract][Full Text] [Related]
30. Regulation of matrix metalloproteinases: an overview.
Chakraborti S; Mandal M; Das S; Mandal A; Chakraborti T
Mol Cell Biochem; 2003 Nov; 253(1-2):269-85. PubMed ID: 14619979
[TBL] [Abstract][Full Text] [Related]
31. Threonine 98, the pivotal residue of tissue inhibitor of metalloproteinases (TIMP)-1 in metalloproteinase recognition.
Lee MH; Rapti M; Knaüper V; Murphy G
J Biol Chem; 2004 Apr; 279(17):17562-9. PubMed ID: 14734567
[TBL] [Abstract][Full Text] [Related]
32. Matrix metalloproteinases in neuroinflammation.
Rosenberg GA
Glia; 2002 Sep; 39(3):279-91. PubMed ID: 12203394
[TBL] [Abstract][Full Text] [Related]
33. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion.
Bourboulia D; Stetler-Stevenson WG
Semin Cancer Biol; 2010 Jun; 20(3):161-8. PubMed ID: 20470890
[TBL] [Abstract][Full Text] [Related]
34. Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.
Georgiadis D; Yiotakis A
Bioorg Med Chem; 2008 Oct; 16(19):8781-94. PubMed ID: 18790648
[TBL] [Abstract][Full Text] [Related]
35. A complete expression profile of matrix-degrading metalloproteinases in Dupuytren's disease.
Johnston P; Chojnowski AJ; Davidson RK; Riley GP; Donell ST; Clark IM
J Hand Surg Am; 2007 Mar; 32(3):343-51. PubMed ID: 17336841
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive gene expression profiling and functional analysis of matrix metalloproteinases and TIMPs, and identification of ADAM-10 gene expression, in a corneal model of epithelial resurfacing.
Gordon GM; Austin JS; Sklar AL; Feuer WJ; LaGier AJ; Fini ME
J Cell Physiol; 2011 Jun; 226(6):1461-70. PubMed ID: 20625997
[TBL] [Abstract][Full Text] [Related]
37. Role of matrix metalloproteinases and their inhibitors in tumor invasion and metastasis.
Khasigov PZ; Podobed OV; Gracheva TS; Salbiev KD; Grachev SV; Berezov TT
Biochemistry (Mosc); 2003 Jul; 68(7):711-7. PubMed ID: 12946252
[TBL] [Abstract][Full Text] [Related]
38. Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics.
Raeeszadeh-Sarmazdeh M; Do LD; Hritz BG
Cells; 2020 May; 9(5):. PubMed ID: 32466129
[TBL] [Abstract][Full Text] [Related]
39. Regulation of ovarian extracellular matrix remodelling by metalloproteinases and their tissue inhibitors: effects on follicular development, ovulation and luteal function.
Smith MF; McIntush EW; Ricke WA; Kojima FN; Smith GW
J Reprod Fertil Suppl; 1999; 54():367-81. PubMed ID: 10692869
[TBL] [Abstract][Full Text] [Related]
40. Variability in melanoma metalloproteinase expression profiling.
Giricz O; Lauer JL; Fields GB
J Biomol Tech; 2010 Dec; 21(4):194-204. PubMed ID: 21119930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
